Trend-Following Backtester · Guide · backtest 한국어

equity · SA

Mouwasat Medical Services Co. backtest

10 trend-following strategies were compared on the full daily history of Mouwasat Medical Services Co.. 0 beat buy-and-hold CAGR; EMA 크로스오버 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is EMA 크로스오버 (CAGR 10.5%, MDD -35.3%).

Data 2010-02-22 ~ 2026-07-30daily bars 4,160 (16.4 years)Costs 0.5%Venue TADAWULMonthly snapshot 2026-07-31

Results by strategy

0 of 10 beat buy and hold (CAGR 13.6%, drawdown -58.5%).

Sharpe leader (same as main): EMA 크로스오버 — CAGR 10.5%, MDD -35.3%, Sharpe 0.55, 65% exposure.

Return/drawdown alternative: EMA 크로스오버 — CAGR is 3.1%p lower than buy and hold, while drawdown improves by 23.2%p (CAGR 10.5%, MDD -35.3%, exposure 65%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
EMA 크로스오버
fast=7, slow=200
10.5%-35.3%0.550.305.2x4465%
Donchian 채널 돌파
entryN=94, exitN=74
8.9%-34.3%0.500.264.0x2259%
SMA 크로스오버
fast=50, slow=95
9.1%-31.8%0.490.284.2x4461%
ADX / DI 방향성
period=65, threshold=16
6.6%-34.7%0.470.192.9x2434%
ROC 모멘텀
n=140, threshold=-0.04
6.2%-61.4%0.370.102.7x11472%
Supertrend
period=23, mult=5
4.2%-58.9%0.290.072.0x5663%
Keltner 채널 돌파
emaPeriod=23, atrPeriod=9, mult=3.1
2.5%-28.5%0.280.091.5x3813%
볼린저 밴드 돌파
n=75, k=3.3
1.9%-21.5%0.220.091.4x1412%
Parabolic SAR
step=0.01, maxStep=0.22
-3.1%-68.8%-0.04-0.050.6x19053%
MACD
fast=16, slow=21, signal=14
-5.2%-72.5%-0.15-0.070.4x26750%
Buy and hold13.6%-58.5%0.570.238.1x1100%
1x 10x 2011 2013 2015 2017 2019 2021 2023 2025 EMA 크로스오버Buy and hold
EMA 크로스오버: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -15% -29% -44% -58% 2011 2013 2015 2017 2019 2021 2023 2025 Buy and holdEMA 크로스오버
EMA 크로스오버 maximum drawdown -35.3% (2022-08-10 → 2024-08-04), prior peak not yet recovered.

Rules of the top strategy

Uses two exponential averages (more weight on recent prices) and trades their crossover.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next